Aldeyra Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
ALDX
CUSIP
01438T106
Type
Equity
Class
COM
Num filers
107
Total reported value, excl. options
$77.7M
Manager Report Date Value ($000) Shares Option Type